BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
- Research and development, 2025
- $10.0B
- YoY, 2025
- −10.8%
- 5-year CAGR
- −0.2%
- 10-year CAGR
- +5.3%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $10.0B | −10.8% |
| 2024 | $11.2B | +20.0% |
| 2023 | $9.3B | −2.2% |
| 2022 | $9.5B | −6.7% |
| 2021 | $10.2B | +1.5% |
| 2020 | $10.0B | +63.4% |
| 2019 | $6.1B | −2.9% |
| 2018 | $6.3B | −2.1% |
| 2017 | $6.5B | +29.1% |
| 2016 | $5.0B | −15.3% |
| 2015 | $5.9B | +30.6% |
| 2014 | $4.5B | +21.5% |
| 2013 | $3.7B | −4.4% |
| 2012 | $3.9B | +1.7% |
| 2011 | $3.8B | +7.7% |
| 2010 | $3.6B | −2.2% |
| 2009 | $3.6B | +3.8% |
| 2008 | $3.5B | +11.1% |
| 2007 | $3.2B | — |